Dr. Mei Changlin
梅长林
Hospital
Changzheng Hospital, Naval Medical University, Shanghai
Experience
35+ years in nephrology
Languages
Mandarin, English
Professor; Chief Physician; Director of the Department of Nephrology; Doctoral Supervisor; Chairman of the Kidney Disease Committee of the Shanghai Medical Association
China's foremost authority on autosomal dominant polycystic kidney disease (ADPKD) — established the country's largest PKD clinical database and research program; led clinical trials evaluating tolvaptan and other emerging therapies for PKD in Chinese populations; developed standardized management protocols for PKD patients that have been adopted nationally; served as committee chairman within the Chinese Society of Nephrology for renal replacement therapy; published over 300 peer-reviewed papers on PKD pathogenesis and treatment; awarded military and Shanghai municipal science and technology prizes
Dr. Mei is the definitive choice for international patients with polycystic kidney disease seeking expert management in China. Changzheng Hospital's PKD clinic offers comprehensive genetic counseling, imaging-based volume assessment, and access to the latest clinical trials. As a military-affiliated hospital in central Shanghai, administrative processes may differ slightly from civilian hospitals — the international patient coordinator can facilitate registration. Patients with PKD should bring family history documentation and serial renal imaging for disease progression assessment.
Research this doctor's background on trusted platforms.
Results are automated searches and may include other individuals with similar names.
Information is provided for reference only and may not reflect current conditions. Please verify directly with the hospital before making decisions.